Atlas Trials

Oncopeptides AB

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Oncopeptides AB

RecordFirmDate
A Study of OPD5 Followed by Autologous Stem Cell Transplant for Patients With Relapsed Refractory Multiple Myeloma (NCT04918511)Oncopeptides AB2021-05-27
Study of Melflufen (Melphalan Flufenamide) in Combination With Daratumumab in Relapsed-Refractory Multiple Myeloma (NCT04649060)Oncopeptides AB2020-12-21
A Clinical Study of Melphalan Flufenamide (Melflufen) and Dexamethasone for Patients With Immunoglobulin Light Chain (AL) Amyloidosis (NCT04115956)Oncopeptides AB2020-08-06
A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients (NCT04412707)Oncopeptides AB2020-08-04
PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function (NCT03639610)Oncopeptides AB2018-08-28
Study of Melphalan Flufenamide (Melflufen) + Dex With Bortezomib or Daratumumab in Patients With RRMM (NCT03481556)Oncopeptides AB2018-04-12

Track Oncopeptides AB automatically

Every clearance here is in the API, with alerts when new ones post.